OTC Watch

All stocks / CNBX

CNBX Pharmaceuticals Inc. CNBX

CNBX Pharmaceuticals (CNBX): shares outstanding up 1636% in a year, convertible notes mentioned in an 8-K in March 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

DilutionEstimated floatCostly financing OTCIDMaryland, USA
Live quote on OTC Markets

Market listing

Full name
CNBX PHARMACEUTICALS INC
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 16
Website
www.cannabics.com
Source: Stockwatch, 2026-11-17

The financial report, and what it means

Annual figures to 2025-08-31
The report says
Revenue
$0
Net loss
($313,976)
What it means

It spends more than it earns

Under strain

The company lost $313,976 in the year. It reported no sales.

The report says
Cash and cash equivalents
$15,111
Net cash used in operating activities
($171,305)
What it means

The cash could run out soon

Under strain

It had $15,111 in the bank and used about $14,275 a month. At that pace the money lasts about 1 months unless it borrows or sells more shares.

The report says
Total assets
$18,437
Total liabilities
$2,514,730
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $18,437. Its debts and unpaid bills add up to $2.5 million. That is about $136.40 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Dilution2026-06-17

Shares outstanding rose from 92,511,352 (2025-05-31) to 1,605,768,095 (2026-06-17), up 1636%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-06-17

Estimated float about 1,605,768,095 shares as of 2026-06-17: 1,605,768,095 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Costly financing2026-03-17

8-K filed 2026-03-17 mentions: convertible note.

Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record

Shares outstanding

Source: SEC filings
2025-08-31
554.0M
2025-11-20
554.0M
2025-11-30
753.2M
2026-01-12
870.8M
2026-02-28
1.13B
2026-04-14
1.23B
2026-05-31
1.48B
2026-06-17
1.61B

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-12 SCHEDULE 13G/A
2026-10-01 8-KCURRENT REPORT
2026-08-14 SCHEDULE 13G/A
2026-06-24 10-QFORM 10-Q FOR MAY 2026
2026-05-08 SCHEDULE 13G/A
2026-04-14 10-QFORM 10-Q
2026-03-17 8-KFORM 8-K
2026-02-05 SCHEDULE 13G/A
2026-01-14 10-QQUARTERLY REPORT
2025-12-01 10-KFORM 10-K FOR AUG 2025

Common questions about CNBX

Does CNBX file reports with the SEC?

Yes. CNBX Pharmaceuticals files with the SEC under company number 0001343009. The most recent filing we hold is a SCHEDULE 13G/A dated 2026-11-12.

Source record

How many CNBX shares are outstanding?

1,605,768,095 shares as of 2026-06-17, as reported to the SEC. That is up 1636% from 92,511,352 on 2025-05-31.

Source record

Has CNBX filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is CNBX Pharmaceuticals making money?

The company lost $313,976 in the year. It reported no sales. (Annual figures to 2025-08-31. Facts from the company's own report, not a recommendation.)

Source record